Since our last update there have been a few positive changes in the way vaccines were being manufactured and stored to ensure that vaccines are available for all areas of each country:

These changes included vaccines in the forms of pills and patches, to name a few. These alternative vaccines created opportunities to protect people against covid-19 in ways that are effective in countries all around the world. One example in particular was the Molnupiravir drug which was created to ensure easy access for poor countries due to it being manufactured and sold cheaply. Which you can find more about HERE.

Alternatives like the one mentioned above offer a new and life changing approach to make sure that vaccination all communities around the world is a priority to ensure that we are all given an option of choosing whether to be vaccinated or not, ensuring worldwide health.

COVID-19 has not only changed the way we learnt to live but also raised awareness of the importance of vaccine equity.

In our latest update we focused on the inequality with vaccinations against COVID-19, but this is not the only area of health and social care where we can see inequalities within vaccine manufacturing and distributions.

The access to potential life saving vaccines is what many suffer from the most. COVID-19 vaccines are not the only vaccine that many still do not have access to but it is one of the first to shed a light on the inequalities that surround the manufacturing and distribution of prevention against many different diseases.

Although full vaccine equity is still not there, the attention that COVID-19 vaccinations and prevention methods have given to the inequalities within the health and social care industry is a start and offers high hopes that changes will continue to be made to ensure that everyone gets an equal chance of preventing and possibly curing any illness or disease that they may have or start to show signs of.